Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review

Date: July 5, 2017
Pages: 46
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N59FC19CD75EN
Leaflet:

Download PDF Leaflet

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review
Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Novozymes A/S (Novozymes) is a biotech company that produces and sells industrial enzymes and microorganisms. The company develops, produces and distributes enzymes for detergent, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment. Novozymes provides various biopharmaceutical ingredients for the pharmaceutical industry. The company caters products to various industries such as household care, agriculture, biopharmaceuticals, bioenergy, food and beverages, pulp and paper, leather, wastewater and textiles. It has operational presence in various countries such as Denmark, China, India and the US among other countries. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

Jun 27,2017: DONG Energy: One of the largest power stations in Denmark can phase out coal
Mar 23,2017: Residues from Novo Nordisk and Novozymes to be converted into biogas
Dec 05,2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT
Jun 30,2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK
Jun 29,2016: Novozymes and DONG Energy enter into agreement on biological waste sorting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Novozymes A/S - Key Facts
Novozymes A/S - Key Employees
Novozymes A/S - Key Employee Biographies
Novozymes A/S - Major Products and Services
Novozymes A/S - History
Novozymes A/S - Company Statement
Novozymes A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Novozymes A/S - Business Description
Novozymes A/S - Corporate Strategy
Novozymes A/S - SWOT Analysis
SWOT Analysis - Overview
Novozymes A/S - Strengths
Novozymes A/S - Weaknesses
Novozymes A/S - Opportunities
Novozymes A/S - Threats
Novozymes A/S - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Novozymes A/S, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jun 27, 2017: DONG Energy: One of the largest power stations in Denmark can phase out coal
Mar 23, 2017: Residues from Novo Nordisk and Novozymes to be converted into biogas
Dec 05, 2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT
Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK
Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK
Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK
Jun 29, 2016: Novozymes and DONG Energy enter into agreement on biological waste sorting
Jan 19, 2016: Group Financial Statement for 2015: Novozymes
Jan 19, 2016: Novozymes separates its biopharma activities to form independent company

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Novozymes A/S, Key Facts
Novozymes A/S, Key Employees
Novozymes A/S, Key Employee Biographies
Novozymes A/S, Major Products and Services
Novozymes A/S, History
Novozymes A/S, Subsidiaries
Novozymes A/S, Key Competitors
Novozymes A/S, Ratios based on current share price
Novozymes A/S, Annual Ratios
Novozymes A/S, Annual Ratios (Cont.1)
Novozymes A/S, Annual Ratios (Cont.2)
Novozymes A/S, Interim Ratios
Novozymes A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Novozymes A/S, Performance Chart (2012 - 2016)
Novozymes A/S, Ratio Charts

COMPANIES MENTIONED

Royal DSM NV
E. I. du Pont de Nemours and Company
Codexis Inc
Chr. Hansen Holding A/S
BASF SE
Auriga Industries A/S
AB Enzymes GmbH
Skip to top


Ask Your Question

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: